Bob
Senior Member
- Messages
- 16,455
- Location
- England (south coast)
From Judy's letter to the Science editors:
They cannot have any data to support the
conclusion "that laboratory contamination with XMRV produced by a cell line (22Rv1)
derived from these early xenograft experiments is the most likely explanation for
detection of the virus in patient samples. In fact, the authors of this paper know full
well that this explanation cannot explain XMRV integration in human tissue, in situ
hybridization, or antibodies reported in prostate cancer or CFS patients. Furthermore,
all strains of wild rodents have not been examined and other examples of ancestral
XMRV can be found.
They cannot have any data to support the
conclusion "that laboratory contamination with XMRV produced by a cell line (22Rv1)
derived from these early xenograft experiments is the most likely explanation for
detection of the virus in patient samples. In fact, the authors of this paper know full
well that this explanation cannot explain XMRV integration in human tissue, in situ
hybridization, or antibodies reported in prostate cancer or CFS patients. Furthermore,
all strains of wild rodents have not been examined and other examples of ancestral
XMRV can be found.